PureTech Health

PureTech and Seaport Report Positive GlyphAgo Phase 1 Data

BOSTON, June 8, 2026 PureTech Health and its Founded Entity Seaport Therapeutics announced positive results from the multiple-ascending dose...

By cGxPwire Editor
June 10, 2026

Bio-Pharma

PureTech Reports Positive LYT-200 Phase 1b Trial Data

BOSTON, USA, April 22, 2026 PureTech Health plc has announced positive topline results from its Phase 1b clinical trial...

By cGxPwire Editor
April 23, 2026

Bio-Pharma

Deupirfenidone Shows Strong IPF Results in Phase 2b Study

NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...

By cGxPwire Editor
April 3, 2026

Bio-Pharma

PureTech, Seaport Advance GlyphAllo in Depression Therapy

BOSTON, Massachusetts, March 26, 2026 PureTech Health has announced that its founded entity, Seaport Therapeutics, has published first-in-human clinical...

By cGxPwire Editor
March 26, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

PureTech and Seaport Report Positive GlyphAgo Phase 1 Data

PureTech Reports Positive LYT-200 Phase 1b Trial Data

Deupirfenidone Shows Strong IPF Results in Phase 2b Study

PureTech, Seaport Advance GlyphAllo in Depression Therapy